A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
Open Access
- 4 October 2020
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 8 (10), 1526
- https://doi.org/10.3390/microorganisms8101526
Abstract
Hepatitis B virus (HBV) infection remains a global public problem despite the availability of an effective vaccine. In the past decades, nonalcoholic fatty liver disease (NAFLD) has surpassed HBV as the most common cause of chronic liver disease worldwide. The prevalence of concomitant chronic hepatitis B (CHB) and NAFLD thus reaches endemic proportions in geographic regions where both conditions are common. Patients with CHB and NAFLD are at increased risk of liver disease progression to cirrhosis and hepatocellular carcinoma. Due to the complexity of the pathogenesis, accurate diagnosis of NAFLD in CHB patients can be challenging. Liver biopsy is considered the gold standard for diagnosing and determining disease severity, but it is an invasive procedure with potential complications. There is a growing body of literature on the application of novel noninvasive serum biomarkers and advanced radiological modalities to diagnose and evaluate NAFLD, but most have not been adequately validated, especially for patients with CHB. Currently, there is no approved therapy for NAFLD, although many new agents are in different phases of development. This review provides a summary of the epidemiology, clinical features, diagnosis, and management of the NAFLD and highlights the unmet needs in the areas of CHB and NAFLD coexistence.Keywords
This publication has 165 references indexed in Scilit:
- Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease populationBMC Gastroenterology, 2012
- Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver diseaseJournal of Hepatology, 2011
- Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: A cross-sectional studyNutrition Journal, 2011
- Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis BWorld Journal of Gastroenterology, 2011
- Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitisJournal of Lipid Research, 2010
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisThe New England Journal of Medicine, 2010
- The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trialTherapeutic Advances in Gastroenterology, 2009
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trialScandinavian Journal of Gastroenterology, 2009
- Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-AnalysisGastroenterology, 2008
- The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLDJournal of Hepatology, 2007